Chemoinformaics analysis of 2-ETHENYL-2,6,6-TRIMETHYLOXANE
| Molecular Weight | 154.253 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 16 |
| Exact Molecular Weight | 154.136 | nRing | 1 |
| Solubility: LogS | -2.467 | nHRing | 1 |
| Solubility: LogP | 1.72 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 0 | BPOL | 19.7937 |
| QED | 0.595 |
| Synth | 5.01 |
| Natural Product Likeliness | 3.549 |
| NR-PPAR-gamma | 0.091 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.007 |
| Pgp-sub | 0.032 |
| HIA | 0.064 |
| CACO-2 | -4.766 |
| MDCK | 0.00000916 |
| BBB | 0.715 |
| PPB | 0.744345 |
| VDSS | 1.029 |
| FU | 0.214854 |
| CYP1A2-inh | 0.011 |
| CYP1A2-sub | 0.261 |
| CYP2c19-inh | 0.01 |
| CYP2c19-sub | 0.836 |
| CYP2c9-inh | 0.046 |
| CYP2c9-sub | 0.072 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.097 |
| CYP3a4-inh | 0.402 |
| CYP3a4-sub | 0.251 |
| CL | 8.687 |
| T12 | 0.414 |
| hERG | 0.006 |
| Ames | 0.034 |
| ROA | 0.06 |
| SkinSen | 0.033 |
| Carcinogencity | 0.103 |
| EI | 0.01 |
| Respiratory | 0.161 |
| NR-Aromatase | 0.68 |
| Antiviral | No |
| Prediction | 0.926017 |